Загрузка...
New Oral Anticoagulants for the Treatment of Venous Thromboembolism: Understanding Differences and Similarities
Venous thromboembolism (VTE) is a major cause of morbidity, mortality, and healthcare expenditure. In the United States, approximately 0.1 % of the population experiences an initial VTE event each year. Anticoagulation therapy is the cornerstone of acute VTE treatment and for prevention of recurrent...
Сохранить в:
| Опубликовано в: : | Drugs |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Springer International Publishing
2014
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4224738/ https://ncbi.nlm.nih.gov/pubmed/25300410 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40265-014-0301-x |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|